The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
General Anesthesia Drugs-Global Market Insights and Sales Trends 2025
Synopsis
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
The global General Anesthesia Drugs market size is expected to reach US$ 4982.9 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of General Anesthesia Drugs in various end use industries. The expanding demands from the Intravenous Anesthetics and Inhalational Anesthetics, are propelling General Anesthesia Drugs market. Propofol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sevoflurane segment is estimated at % CAGR for the next seven-year period.
Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for General Anesthesia Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global General Anesthesia Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global General Anesthesia Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, General Anesthesia Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of General Anesthesia Drugs covered in this report include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and Yichang Humanwell, etc.
The global General Anesthesia Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Global General Anesthesia Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global General Anesthesia Drugs market, Segment by Type:
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Others
Global General Anesthesia Drugs market, by Application
Intravenous Anesthetics
Inhalational Anesthetics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
The global General Anesthesia Drugs market size is expected to reach US$ 4982.9 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of General Anesthesia Drugs in various end use industries. The expanding demands from the Intravenous Anesthetics and Inhalational Anesthetics, are propelling General Anesthesia Drugs market. Propofol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sevoflurane segment is estimated at % CAGR for the next seven-year period.
Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for General Anesthesia Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global General Anesthesia Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global General Anesthesia Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, General Anesthesia Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of General Anesthesia Drugs covered in this report include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and Yichang Humanwell, etc.
The global General Anesthesia Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Global General Anesthesia Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global General Anesthesia Drugs market, Segment by Type:
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Others
Global General Anesthesia Drugs market, by Application
Intravenous Anesthetics
Inhalational Anesthetics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 General Anesthesia Drugs Market Overview
1.1 General Anesthesia Drugs Product Overview
1.2 General Anesthesia Drugs Market Segment by Type
1.2.1 Propofol
1.2.2 Sevoflurane
1.2.3 Remifentanil
1.2.4 Etomidate
1.2.5 Isoflurane
1.2.6 Others
1.3 Global General Anesthesia Drugs Market Size by Type
1.3.1 Global General Anesthesia Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global General Anesthesia Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global General Anesthesia Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America General Anesthesia Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe General Anesthesia Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific General Anesthesia Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America General Anesthesia Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa General Anesthesia Drugs Sales Breakdown by Type (2018-2023)
2 Global General Anesthesia Drugs Market Competition by Company
2.1 Global Top Players by General Anesthesia Drugs Sales (2018-2023)
2.2 Global Top Players by General Anesthesia Drugs Revenue (2018-2023)
2.3 Global Top Players by General Anesthesia Drugs Price (2018-2023)
2.4 Global Top Manufacturers General Anesthesia Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 General Anesthesia Drugs Market Competitive Situation and Trends
2.5.1 General Anesthesia Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by General Anesthesia Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in General Anesthesia Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into General Anesthesia Drugs Market
2.8 Key Manufacturers General Anesthesia Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 General Anesthesia Drugs Status and Outlook by Region
3.1 Global General Anesthesia Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global General Anesthesia Drugs Historic Market Size by Region
3.2.1 Global General Anesthesia Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global General Anesthesia Drugs Sales in Value by Region (2018-2023)
3.2.3 Global General Anesthesia Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global General Anesthesia Drugs Forecasted Market Size by Region
3.3.1 Global General Anesthesia Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global General Anesthesia Drugs Sales in Value by Region (2024-2029)
3.3.3 Global General Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global General Anesthesia Drugs by Application
4.1 General Anesthesia Drugs Market Segment by Application
4.1.1 Intravenous Anesthetics
4.1.2 Inhalational Anesthetics
4.2 Global General Anesthesia Drugs Market Size by Application
4.2.1 Global General Anesthesia Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global General Anesthesia Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global General Anesthesia Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America General Anesthesia Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe General Anesthesia Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific General Anesthesia Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America General Anesthesia Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa General Anesthesia Drugs Sales Breakdown by Application (2018-2023)
5 North America General Anesthesia Drugs by Country
5.1 North America General Anesthesia Drugs Historic Market Size by Country
5.1.1 North America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America General Anesthesia Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America General Anesthesia Drugs Sales in Value by Country (2018-2023)
5.2 North America General Anesthesia Drugs Forecasted Market Size by Country
5.2.1 North America General Anesthesia Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America General Anesthesia Drugs Sales in Value by Country (2024-2029)
6 Europe General Anesthesia Drugs by Country
6.1 Europe General Anesthesia Drugs Historic Market Size by Country
6.1.1 Europe General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe General Anesthesia Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe General Anesthesia Drugs Sales in Value by Country (2018-2023)
6.2 Europe General Anesthesia Drugs Forecasted Market Size by Country
6.2.1 Europe General Anesthesia Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe General Anesthesia Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific General Anesthesia Drugs by Region
7.1 Asia-Pacific General Anesthesia Drugs Historic Market Size by Region
7.1.1 Asia-Pacific General Anesthesia Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific General Anesthesia Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific General Anesthesia Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific General Anesthesia Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific General Anesthesia Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific General Anesthesia Drugs Sales in Value by Region (2024-2029)
8 Latin America General Anesthesia Drugs by Country
8.1 Latin America General Anesthesia Drugs Historic Market Size by Country
8.1.1 Latin America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America General Anesthesia Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America General Anesthesia Drugs Sales in Value by Country (2018-2023)
8.2 Latin America General Anesthesia Drugs Forecasted Market Size by Country
8.2.1 Latin America General Anesthesia Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America General Anesthesia Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa General Anesthesia Drugs by Country
9.1 Middle East and Africa General Anesthesia Drugs Historic Market Size by Country
9.1.1 Middle East and Africa General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa General Anesthesia Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa General Anesthesia Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa General Anesthesia Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa General Anesthesia Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa General Anesthesia Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Aspen Pharma
10.1.1 Aspen Pharma Company Information
10.1.2 Aspen Pharma Introduction and Business Overview
10.1.3 Aspen Pharma General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Aspen Pharma General Anesthesia Drugs Products Offered
10.1.5 Aspen Pharma Recent Development
10.2 Fresenius-Kabi
10.2.1 Fresenius-Kabi Company Information
10.2.2 Fresenius-Kabi Introduction and Business Overview
10.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Fresenius-Kabi General Anesthesia Drugs Products Offered
10.2.5 Fresenius-Kabi Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Information
10.3.2 AbbVie Introduction and Business Overview
10.3.3 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AbbVie General Anesthesia Drugs Products Offered
10.3.5 AbbVie Recent Development
10.4 Baxter Healthcare
10.4.1 Baxter Healthcare Company Information
10.4.2 Baxter Healthcare Introduction and Business Overview
10.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Baxter Healthcare General Anesthesia Drugs Products Offered
10.4.5 Baxter Healthcare Recent Development
10.5 B.Braun
10.5.1 B.Braun Company Information
10.5.2 B.Braun Introduction and Business Overview
10.5.3 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 B.Braun General Anesthesia Drugs Products Offered
10.5.5 B.Braun Recent Development
10.6 Maruishi
10.6.1 Maruishi Company Information
10.6.2 Maruishi Introduction and Business Overview
10.6.3 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Maruishi General Anesthesia Drugs Products Offered
10.6.5 Maruishi Recent Development
10.7 Piramal
10.7.1 Piramal Company Information
10.7.2 Piramal Introduction and Business Overview
10.7.3 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Piramal General Anesthesia Drugs Products Offered
10.7.5 Piramal Recent Development
10.8 Hikma Pharmaceuticals
10.8.1 Hikma Pharmaceuticals Company Information
10.8.2 Hikma Pharmaceuticals Introduction and Business Overview
10.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Products Offered
10.8.5 Hikma Pharmaceuticals Recent Development
10.9 Yichang Humanwell
10.9.1 Yichang Humanwell Company Information
10.9.2 Yichang Humanwell Introduction and Business Overview
10.9.3 Yichang Humanwell General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Yichang Humanwell General Anesthesia Drugs Products Offered
10.9.5 Yichang Humanwell Recent Development
10.10 Nhwa
10.10.1 Nhwa Company Information
10.10.2 Nhwa Introduction and Business Overview
10.10.3 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Nhwa General Anesthesia Drugs Products Offered
10.10.5 Nhwa Recent Development
10.11 Hengrui
10.11.1 Hengrui Company Information
10.11.2 Hengrui Introduction and Business Overview
10.11.3 Hengrui General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hengrui General Anesthesia Drugs Products Offered
10.11.5 Hengrui Recent Development
10.12 Xi'an Libang
10.12.1 Xi'an Libang Company Information
10.12.2 Xi'an Libang Introduction and Business Overview
10.12.3 Xi'an Libang General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Xi'an Libang General Anesthesia Drugs Products Offered
10.12.5 Xi'an Libang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 General Anesthesia Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 General Anesthesia Drugs Industrial Chain Analysis
11.4 General Anesthesia Drugs Market Dynamics
11.4.1 General Anesthesia Drugs Industry Trends
11.4.2 General Anesthesia Drugs Market Drivers
11.4.3 General Anesthesia Drugs Market Challenges
11.4.4 General Anesthesia Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 General Anesthesia Drugs Distributors
12.3 General Anesthesia Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
